Worldwide, hepatitis B virus is the major risk factor for hepatocellular carcinoma (HCC), owing to ... surveillance regimes of α-fetoprotein and ultrasound may be augmented by novel biomarkers ...

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

Announcing a new publication for Acta Materia Medica journal. Icaritin (ICA) is a prenylflavonoid natural product extracted from plants of the Epimedium genus.

This study investigated the long-term prognosis and clinical course of patients who survived for more than 5 years after hepatocellular carcinoma (HCC) diagnosis.This retrospective cohort study used ...

Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...

Cells have surface receptors called integrins that bind to repetitive domains present on the extracellular matrix (ECM) surrounding the cells, allowing them to grow and spread. A new study from the ...

Tweaking the spacing between binding domains on the ECM surrounding cancer cells can boost their killing via ultrasound ...

A research team led by Professor Kevin Tsia, program director of the Biomedical Engineering Program under the Faculty of ...

Atria Health, a physician-owned company that helps independent cardiology practices thrive, today announced its nationwide launch to scale ...

The CytoMAD tool leverages microfluidic technology for 'label-free' imaging, allowing clinicians to examine tumour cells.